Palpeon MT-20 20,000 UNT / 65,000 UNT / 65,000 UNT Delayed Release Oral Capsule
RxNorm 763165
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 763165 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Palpeon MT-20 20,000 UNT / 65,000 UNT / 65,000 UNT Delayed Release Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Amylase 65000 UNT / lipase 20000 UNT / protease 65000 UNT Delayed Release Oral Capsule [Palpeon]
(Atom ID: 12361134)
SY
Synonym (SY):
Palpeon MT 20 (amylase 65,000 UNT / protease 65,000 UNT / lipase 20,000 UNT) Delayed Release Oral Capsule
(Atom ID: 11845977)
SY
Synonym (SY):
Palpeon MT 20 (amylases 65,000 UNT / endopeptidases 65,000 UNT / lipase 20,000 UNT) Delayed Release Oral Capsule
(Atom ID: 11845976)
PSN